Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease
1. Major adverse cardiovascular and cerebrovascular events were significantly reduced with clopidogrel compared to aspirin alone. 2. There was no ...
Tag: antiplatelet
Ticagrelor with aspirin may be superior to clopidogrel and aspirin for preventing stroke in certain patients
1. In this post-hoc analysis of the CHANCE-2 trial, ticagrelor-acetylsalicylic acid was more beneficial compared to clopidogrel-acetylsalicylic acid for preventing ...
#VisualAbstract: Clopidogrel plus aspirin reduces new stroke risk but increases bleeding risk compared to aspirin alone following ischemic stroke
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Aspirin use was not effective at reducing mortality in patients hospitalized with COVID-19
1. There was no significant difference in all-cause mortality and need for invasive mechanical ventilation among patients assigned to aspirin ...
Clopidogrel monotherapy is superior to aspirin monotherapy for chronic maintenance after percutaneous coronary intervention
1. Clopidogrel monotherapy reduced long-term rates of all-cause mortality, non-fatal myocardial infarction, and stroke after drug-eluting stent placement compared with ...
![Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Taxus_stent_FDA-e1607803635904-350x250.jpg)
Tailored antiplatelet therapy improves outcomes in patients undergoing percutaneous coronary intervention
1. Guided selection of antiplatelet therapy reduced rates of major adverse cardiovascular event rates compared to standard therapy. 2. Guided ...
Perioperative changes of response to antiplatelet medication in vascular surgery patients
1. The incidence of having reduced antiplatelet activity to aspirin (ALR) increased after vascular procedures. Evidence Rating Level: 1 (Excellent) ...
Ticagrelor non-superior to clopidogrel in the reduction of PCI-related myocardial necrosis
1. There was no significant difference in periprocedural myonecrosis between ticagrelor and clopidogrel among patients undergoing high-risk elective PCI. 2. ...
No significant differences in outcomes between pre- and post-treatment administration of P2Y12 inhibitors for NSTE-ACS
1. There does not appear to be any difference in outcome between pre- and post-treatment administration of P2Y12 inhibitors among ...
Rivaroxaban after TAVR linked with increased risk of adverse events compared to antiplatelet therapy
1. After successful transcatheter aortic valve replacement, compared to an anti-platelet based strategy, patients that received an anti-coagulation strategy including ...
